Tag Archives: COVID19

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication… Read More »

COVID-19 hasn’t just spotlighted healthcare inequity – it’s made it worse

The COVID-19 crisis has shined a light on the existing discrepancies in the healthcare system, with patients of color more likely to test positive for and suffer more severe health consequences from the novel coronavirus.  In addition, said panelists at Equal Access to Care for All Communities, a recent HIMSS Global Health Equity Week webinar,… Read More »

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

Budrul Chukrut | LightRocket | Getty Images The study of Johnson & Johnson‘s Covid-19 vaccine has been paused due to an unexplained illness in a study participant. A document sent to outside researchers running the 60,000-patient clinical trial states that a “pausing rule” has been met, that the online system used to enroll patients in… Read More »